Hims & Hers Health Inc (HIMS)
NYSE • Healthcare
June 11, 2026 at 20:00 UTC
About Hims & Hers Health Inc
Hims & Hers Health operates dual consumer brands — Hims and Hers — through a telehealth platform that pairs online medical consultations with prescription fulfillment, over-the-counter treatments, and personal care products. Clinical categories cover dermatology, sexual health, mental wellness, hair care, weight management, and primary care screenings, all accessible via a mobile application and website. Licensed providers evaluate patients asynchronously or through scheduled video visits, and prescriptions are dispensed by the company's affiliated pharmacy operations, which manage the entire chain from verification through packaging and shipping. Distribution extends through a direct-to-consumer channel and select retail partnerships across the United States, blending digital acquisition with physical shelf presence.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Hims & Hers Health Inc's Technical Indicators Summary
HIMS shows short- to medium-term bullishness with price above the 10–50 day averages and MACD and momentum measures signaling strength, while RSI sits in consolidation territory. The stock remains below its 200-day average, however, and ADX around 18 suggests the trend is not especially strong. Volatility is elevated with ATR above 7%, and OBV gives mixed signals despite price gains; pivot levels are roughly neutral. Technical takeaway: Bullish — near-term momentum is constructive but the stock is still below the long-term average and volatility is high.
| Indicator | Value |
|---|---|
RSI (14) | 59.37 |
Stochastic %K (14, 3, 3) | 82.19 |
CCI (20) | 97.90 |
WPR (14) | -14.57 |
Momentum (10) | 3.49 |
MFI | 81.60 |
MACD Level (12, 26) | 0.83 |
Bollinger Bands | $21.50 - $30.02 |
ATR (14) | $2.12 (7.33%) |
ADX (14) | 18.58 |
OBV | -136,191,421 |
Classic Pivot Point | $28.41 |
Fibonacci Pivot Point | $28.41 |
Simple Moving Averages | $23.52 - $33.66(5 indicators) |
Exponential Moving Averages | $25.71 - $34.46(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
By the end of the session, HIMS held much of its 3.85% gain versus yesterday, closing around 28.85. Into the close, HIMS maintained a mild bullish bias in derivatives, as the put/call ratio stayed near 0.51. HIMS climbs as GLP-1 tailwinds shift to branded distribution, supporting its bullish tilt.
Price Change
from $27.78 close
+$1.09
Trading Volume
Below avg (18.2M)
12.4M
vs S&P 500 Today
Underperforming Market
-0.67%
52-Week Position
Lower range
26.7%
Updated: June 11, 2026 at 20:05 UTC
Quote Summary
HIMS Headlines
Hims & Hers Plunges on Wegovy Copycat Fallout
February 9, 2026
Hims–Novo Nordisk clash over new weight-loss pill
February 7, 2026
Hims jolts weight‑loss drug market with $49 Wegovy pill
February 5, 2026